ArticleNPJ breast cancer2021

Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid.

Neelima Vidula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.